Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1772457 | 1.00 | — | — | |
| SCHEMBL3077600 | 1.00 | ALDH1A1 (0.43) | ALDH1A1 | |
| SCHEMBL3079047 | 1.00 | ALDH1A1 (0.43) | ALDH1A1 | |
| SCHEMBL360309 | 1.00 | ALDH1A1 (0.43) | ALDH1A1 | |
| SCHEMBL2897919 | 1.00 | ALDH1A1 (0.43) | ALDH1A1 | |
| SCHEMBL3078484 | 1.00 | ALDH1A1 (0.43) | ALDH1A1 | |
| SCHEMBL3078185 | 1.00 | ALDH1A1 (0.43) | ALDH1A1 | |
| SCHEMBL3073379 | 1.00 | ALDH1A1 (0.43) | ALDH1A1 | |
| SCHEMBL3031889 | 1.00 | ALDH1A1 (0.43) | ALDH1A1 | |
| SCHEMBL3064137 | 1.00 | ALDH1A1 (0.43) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1372 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121554629-B | Preparation method and application of macrocyclic polyamine-based porous organic aerogel | 浙江理工大学嵊州创新研究院有限公司 | 2026-05-12 | — | — | CN | claimed |
| EP-4688828-A1 | RADIOPHARMACEUTICAL CONJUGATE COMPOUND FOR DIAGNOSIS AND/OR THERAPEUTIC USES THEREOF | Jubilant DraxImage Inc. (CA) | 2026-02-11 | — | — | EP | claimed |
| CN-115737845-B | CD47 specific molecular imaging probe and preparation method and application thereof | 上海交通大学医学院附属仁济医院 | 2025-05-13 | — | — | CN | claimed |
| US-12226494-B2 | Pharmaceutical compositions comprising Gd-complexes and polyarylene additives | BRACCO IMAGING S.P.A. (IT) | 2025-02-18 | — | — | US | claimed |
| EP-4486395-A1 | PRECURSOR MARKERS AND RADIOTRACERS WITH THREE OR MORE TARGETING VECTORS FOR THERANOSTICS USED IN NUCLEAR MEDICINE | Atoms for Cure GmbH (DE) | 2025-01-08 | — | — | EP | claimed |
| WO-2024231837-A1 | NEW BORON-BASED COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE | UNIVERSITA' DEGLI STUDI DI TORINO (IT) | 2024-11-14 | — | — | WO | claimed |
| WO-2024201255-A1 | RADIOPHARMACEUTICAL CONJUGATE COMPOUND FOR DIAGNOSIS AND/OR THERAPEUTIC USES THEREOF | JUBILANT DRAXIMAGE INC. (CA) | 2024-10-03 | — | — | WO | claimed |
| EP-4404981-A1 | RADIOPHARMACEUTICAL COMPLEX FOR IMAGING AND/OR LOCALIZING PSMA POSITIVE CELLS | Scogif S.r.l. (IT) | 2024-07-31 | — | — | EP | claimed |
| US-20240228663-A9 | ANTI-CHITINASE-3-LIKE PROTEIN-1 (YKL-40) NEUTRALIZING ANTIBODY AND USES THEREOF | Institute of Nuclear Energy Research, Atomic Energy Council, Executive Yuan, R.O.C (TW) | 2024-07-11 | — | — | US | claimed |
| US-20240165281-A1 | DUAL MODE RADIOTRACER AND THERAPEUTICS | UNIV MUENCHEN TECH (DE) | 2024-05-23 | — | — | US | claimed |
| WO-1995009161-A1 | HEPATOBILIARY MAGNETIC RESONANCE CONTRAST AGENTS | BRACCO INTERNATIONAL B.V. (NL) | 1995-04-06 | — | — | WO | claimed |
| EP-0545983-B1 | INTERMEDIATES FOR CHELATING AGENTS WITH PREFIXED SYMMETRY AND PROCESS FOR THEIR PREPARATION | BRACCO SPA (IT) | 1994-10-26 | — | — | EP | claimed |
| US-5358704-A | Hepatobiliary tetraazamacrocyclic magnetic resonance contrast agents | BRISTOL-MYERS SQUIBB (US) | 1994-10-25 | — | — | US | claimed |
| EP-0618910-A1 | SYNTHESIS OF POLYAZAMACROCYCLES WITH MORE THAN ONE TYPE OF SIDE-CHAIN CHELATING GROUPS | THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1994-10-12 | — | — | EP | claimed |
| US-5277895-A | Nuclear magnetic resonance | SCHERING AKTIENGESELLSCHAFT (DE) | 1994-01-11 | — | — | US | claimed |
| EP-0545983-A1 | INTERMEDIATES FOR CHELATING AGENTS WITH PREFIXED SYMMETRY AND PROCESS FOR THEIR PREPARATION. | BRACCO SPA (IT) | 1993-06-16 | — | — | EP | claimed |
| EP-0545511-A2 | Process for the preparation of mono-N-substituted tetraazamacrocycles | SCHERING AKTIENGESELLSCHAFT (DE) | 1993-06-09 | — | — | EP | claimed |
| WO-1992004336-A1 | INTERMEDIATES FOR CHELATING AGENTS WITH PREFIXED SYMMETRY AND PROCESS FOR THEIR PREPARATION | BRACCO INDUSTRIA CHIMICA S.P.A. (IT) | 1992-03-19 | — | — | WO | claimed |
| US-4915933-A | Nuclear magnetic resonance | THE UNIVERSITY OF NEW MEXICO (US) | 1990-04-10 | — | — | US | claimed |
| EP-0325307-A2 | Macrocyclic polyamine multifunctional lubricating oil additives | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1989-07-26 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240165281-A1 | DUAL MODE RADIOTRACER AND THERAPEUTICS | FOLH1, KLK3, PAICS | ALDH1A1 1244/4885 |
| US-12226494-B2 | Pharmaceutical compositions comprising Gd-complexes and polyarylene additives | GRN, GALC, ABCB11 | ALDH1A1 3585/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.